What is the current valuation of the France Morphine Market?

As of 2024, the France Morphine Market was valued at 1.08 USD Billion. Read More

What is the projected market size for the France Morphine Market by 2035?

The market is projected to reach 2.16 USD Billion by 2035. Read More

What is the expected CAGR for the France Morphine Market during the forecast period?

The expected CAGR for the France Morphine Market from 2025 to 2035 is 6.5%. Read More

Which application segments are driving the France Morphine Market?

The Pain Management segment is anticipated to grow from 0.54 to 0.96 USD Billion, indicating strong demand. Read More

How does the distribution channel impact the France Morphine Market?

Hospitals are projected to dominate the distribution channel, increasing from 0.54 to 0.96 USD Billion. Read More

What are the key players in the France Morphine Market?

Key players include Sanofi, Mundipharma, Purdue Pharma, and Teva Pharmaceuticals, among others. Read More

What formulation types are available in the France Morphine Market?

The market includes Injectable, Oral, Transdermal, and Sustained Release formulations, with Injectables expected to grow significantly. Read More

What is the expected growth in the Palliative Care segment?

The Palliative Care segment is projected to increase from 0.24 to 0.48 USD Billion, reflecting rising demand. Read More

How are home care services influencing the France Morphine Market?

Home Care services are expected to grow from 0.24 to 0.48 USD Billion, indicating a shift towards at-home treatment options. Read More

What role do research institutions play in the France Morphine Market?

Research Institutions are projected to contribute between 0.12 and 0.24 USD Billion, highlighting their importance in market development. Read More

France Morphine Market

ID: MRFR/HC/49741-HCR

200 Pages

Vikita Thakur

Last Updated: March 30, 2026

France Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035

France Morphine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.5%

2018 Market Size$ 810 Million

2024 Market Size$ 1.08 Billion

2035 Market Size$ 2.16 Billion

Key Players

Sanofi

Mundipharma

Purdue Pharma

Teva Pharmaceuticals

Mallinckrodt Pharmaceuticals

AstraZeneca

Trends

Regulatory Compliance and Quality Assurance
Innovations in Pain Management
Collaborative Approaches to Opioid Use

Opportunities

Rising Incidence of Chronic Pain
Increased Awareness and Education
Collaborative Healthcare Approaches

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 France Morphine Market, BY Application (USD Billion)
  1. 4.1.1 Pain Management
  2. 4.1.2 Palliative Care
  3. 4.1.3 Anesthesia
  4. 4.1.4 Cough Suppression
2. 4.2 France Morphine Market, BY Formulation Type (USD Billion)
  1. 4.2.1 Injectable
  2. 4.2.2 Oral
  3. 4.2.3 Transdermal
  4. 4.2.4 Sustained Release
3. 4.3 France Morphine Market, BY Distribution Channel (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Pharmacies
  3. 4.3.3 Online Retail
  4. 4.3.4 Specialty Clinics
4. 4.4 France Morphine Market, BY End Use (USD Billion)
  1. 4.4.1 Hospitals
  2. 4.4.2 Home Care
  3. 4.4.3 Long-term Care Facilities
  4. 4.4.4 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the France Morphine Market
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the France Morphine Market
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Sanofi (FR)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mundipharma (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Purdue Pharma (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Teva Pharmaceuticals (IL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Mallinckrodt Pharmaceuticals (IE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 AstraZeneca (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fresenius Kabi (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Hikma Pharmaceuticals (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Boehringer Ingelheim (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION
3. 6.3 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
4. 6.4 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 FRANCE MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF FRANCE MORPHINE MARKET
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FRANCE MORPHINE MARKET
9. 6.9 DRIVERS IMPACT ANALYSIS: FRANCE MORPHINE MARKET
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FRANCE MORPHINE MARKET
11. 6.11 SUPPLY / VALUE CHAIN: FRANCE MORPHINE MARKET
12. 6.12 FRANCE MORPHINE MARKET, BY APPLICATION, 2024 (% SHARE)
13. 6.13 FRANCE MORPHINE MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 FRANCE MORPHINE MARKET, BY FORMULATION TYPE, 2024 (% SHARE)
15. 6.15 FRANCE MORPHINE MARKET, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 FRANCE MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
17. 6.17 FRANCE MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
18. 6.18 FRANCE MORPHINE MARKET, BY END USE, 2024 (% SHARE)
19. 6.19 FRANCE MORPHINE MARKET, BY END USE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION TYPE, 2026-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
  4. 7.2.4 BY END USE, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Morphine Market Segmentation

France Morphine Market By Application (USD Billion, 2022-2035)

Pain Management
Palliative Care
Anesthesia
Cough Suppression

France Morphine Market By Formulation Type (USD Billion, 2022-2035)

Injectable
Oral
Transdermal
Sustained Release

France Morphine Market By Distribution Channel (USD Billion, 2022-2035)

Hospitals
Pharmacies
Online Retail
Specialty Clinics

France Morphine Market By End Use (USD Billion, 2022-2035)

Hospitals
Home Care
Long-term Care Facilities
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”